期刊
BIOANALYSIS
卷 9, 期 11, 页码 849-859出版社
FUTURE SCI LTD
DOI: 10.4155/bio-2017-0048
关键词
antidrug antibody; drug tolerance; ELISA; Fc gamma RI; immune complex assay; immunogenicity; safety assessment; suppressed Fc effector functions; target interference
资金
- Roche Diagnostics GmbH
Aim: Bridging immunoassays for detection of antidrug antibodies (ADAs) are typically susceptible to high concentrations of residual drug. Sensitive drug-tolerant assays are, therefore, needed. Materials & methods: An immune complex assay to detect ADAs against therapeutic antibodies bearing Pro329Gly mutation was established. The assay uses antibodies specific for the Pro329Gly mutation for capture and human soluble Fc gamma receptor for detection. Results: When compared with a bridging assay, the new assay showed similar precision, high sensitivity to IgG1 ADA and dramatically improved drug tolerance. However, it was not able to detect early (IgM-based) immune responses. Conclusion: Applied in combination with a bridging assay, the novel assay serves as orthogonal assay for immunogenicity assessment and allows further characterization of ADA responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据